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The matrix (M) protein of vesicular stomatitis virus (VSV) was reported to form vesicles on the cell surface and
subsequently to be released into the cultured medium when expressed from cDNA by virus vectors. To further investigate
VSV M activity, we generated a recombinant Sendai virus (SeV) expressing the VSV M protein (SeV-MVSV). When cells were
infected with SeV-MVSV, VSV M was found abundantly in the culture medium. Electron microscopy demonstrated the budding
of two-membraned vesicles ($0.8 mm in diameter) from the infected cells. The outer membrane of the vesicle was derived
from the plasma membrane and the inner one possibly derived from the membrane of an intracellular vesicle. Immuno-gold
labeling showed that VSV M was exclusively located in a double-layered region. The released membranes were divided into
three parts: the VSV M vesicles with SeV F and HN glycoproteins, SeV particles, and vesicles associated with the cytosolic
components. The last abundantly contained phosphorylated SeV matrix (M) protein, which is not released in a usual SeV
infection. Furthermore the VSV M protein expressed without using a virus vector was efficiently released into the culture
medium. These results suggest that the VSV M protein has a budding activity per se and that SeV proteins are passively
involved in the release of VSV M. © 1999 Academic PressKey Words: vesicular stomatitis; M protein; Sendai virus; vector; assembly; two-membraned vesicle.
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pINTRODUCTION
Vesicular stomatitis virus (VSV), a prototype of the
habdoviridae, has a bullet-shaped virion enwrapped by
lipid envelope. Inside the virion is a viral nucleocapsid
omposed of a single-stranded negative-sense RNA ge-
ome packed with the nucleocapsid (N) protein, accom-
anying the minor polymerase components, phospho-
rotein (P) and large (L) proteins. VSV has a transmem-
rane glycoprotein, the G protein, which plays a role in
irus attachment to a host cell and in subsequent mem-
rane fusion to initiate infection (Wagner and Rose,
996). Another major viral protein in the virion is the
atrix (M) protein. The M protein has been reported to
ause cytopathogenicity during infection. Expression of
he VSV M protein from cDNA causes cell rounding by
isruption of the cytoskeleton (Blondel et al., 1990; Lyles
nd McKenzie, 1997). Furthermore the VSV M protein
nhibits cellular transcription (Black and Lyles, 1992; Fer-
an and Lucas Lenard, 1997) and inhibits the nuclear
ransport of RNAs and proteins by the Ran translocation
ystem (Her et al., 1997). Although the M protein is
1 To whom correspondence and reprint requests should be ad-
ressed at Department of Bacteriology, Hiroshima University School of
edicine, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan. Fax:p81-82-257-5159. E-mail: takemasa@mcai.med.hiroshima-u.ac.jp.
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230onsidered to be multifunctional, the central roles of the
protein are those of virus assembly and morphogen-
sis. Late in infection, the M protein was shown to
nteract with the nucleocapsid, inhibiting viral transcrip-
ion and inducing condensation of the nucleocapsid
Wagner and Rose, 1996). A part of the M protein inter-
cts with the plasma membrane where subsequent virus
ssembly takes place (Ohno and Ohtake, 1987; Mc-
reedy and Lyles, 1989; Chong and Rose, 1993). The M
rotein then combines the inner helical nucleocapsid
ith the envelope (Wagner and Rose, 1996).
In VSV budding, nucleocapsids are incorporated into
he skeleton-like structure at the marginal region of the
ytoplasm and enwrapped by the plasma membrane and
hen mature virus particles bud off the cell (Lenard,
996). The M protein is considered to be involved in all of
hese viral budding steps. Li et al. (1993) showed that
hen the VSV M protein was expressed without any
ther VSV protein in insect cells, lipid vesicles containing
he VSV M protein were released to the culture medium.
t also was shown that the VSV M protein was released
s a lipid-associated form when expressed in mamma-
ian cultured cells by using a recombinant vaccinia virus
Justice et al., 1995). In this study, release of mutant M
roteins from a temperature-sensitive mutant had a tem-
erature-sensitive phenotype as well, suggesting that
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231DOUBLE-LAYERED MEMBRANE VESICLES BY VSV Mesicle release by the M protein reflects an actual virus
udding in the normal viral life cycle. Hence analysis of
he phenomenon may clarify a function of the M protein
elated to virus budding. In the latter study using mam-
alian cells, however, electron microscopy encountered
ifficulty because of the interference by vaccinia virus
ectors and liposomes used for transfection (Justice et
l., 1995) and detailed observation of the vesicles re-
ained to be elucidated.
Sendai virus (SeV), a prototype of the Paramyxoviridae,
s a pleomorphic enveloped virus that has a single-
tranded negative-sense RNA as a genome. SeV has two
ransmembrane glycoproteins, the fusion (F) and hemag-
lutinin-neuraminidase (HN), in the envelope, and the
atrix (M) protein resides between the envelope and the
nner nucleocapsid, containing the nucleoprotein (N),
hosphoprotein (P), and large (L) proteins (Lamb and
olakofsky, 1996). SeV has recently been available as a
ector to introduce a foreign gene to cells (Hasan et al.,
997), after establishment of the virus recovery system
rom genomic DNA (Kato et al., 1996). Here we ex-
ressed the VSV M protein by a SeV vector to examine
he vesicle formation caused by VSV M. We demon-
trated by electron microscopy that vesicles are re-
eased from the cells expressing VSV M and that the
esicles have double layers of membranes. VSV M was
FIG. 1. (A) Nucleotide sequence around the gene insertion site of pSe
inker, which was located at the 39 noncoding region of the N gene of
nd transcription start and stop signals are boxed. (B) Gene order onxclusively located in the two-membraned region by im- vuno-electron microscopy as if two membranes had
een combined. We also showed the interaction be-
ween the VSV M vesicle and SeV proteins.
RESULTS
ecovery of the SeV carrying the VSV M gene
We generated SeV expressing the VSV M protein. The
SV M gene was inserted between the N and P/C genes
f the SeV genomic DNA as an additional gene, accom-
anying the SeV transcription start and stop signals
ssential for gene expression [pSeV18c(1)-MVSV]. The
ucleotide sequence around the insertion site and gene
rder of the construct are shown in Fig. 1. A recombinant
irus was successfully recovered from the DNA con-
truct and designated as SeV-MVSV.
As reference viruses we used SeV/SpLuc, which had
he firefly luciferase gene at a similar position as
eV-MVSV (A. Kato et al., submitted), and SeV wt, which
as generated from the wild-type genomic DNA. From
nother DNA construct, in which the SeV M gene was
otally replaced with the VSV M (pSeV(1)-MVSV), no virus
as obtained in this recovery system (data not shown),
howing no compatibility of the VSV M protein for SeV
eplication.
The growth efficiency of the recovered virus was in-
)-MVSV. The VSV M cDNA was inserted into the NotI site at the 18 base
nomic DNA. Translation start and stop signals are double underlined,
c(1)-MVSV.V18c(1
SeV ge
pSeV18estigated by inoculating 1000 cell infectious units (CIU)
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232 SAKAGUCHI ET AL.f a virus to an embryonated egg and incubating it at
3°C for 3 days. The final infectivity was (7.6 6 3.9) 3 107
IU/ml for SeV-MVSV, (7.7 6 3.6) 3 108 CIU/ml for SeV/
pLuc, and (3.0 6 1.3) 3 1010 CIU/ml for SeV wt (mean 6
tandard deviation, four eggs per virus). SeV-MVSV had an
pproximately one-tenth greater infectivity than SeV/
pLuc, suggesting the harmful effect of the VSV M pro-
ein to virus replication. The lower infectivity of SeV/
pLuc compared with SeV wt suggests that insertion of
foreign gene between the N and P/C genes impaired
irus growth or it might be due to some inhibitory effect
f a luciferase protein to virus replication.
ynthesis of the VSV M protein in SeV-MVSV-infected
ells
To examine intracellular synthesis of the VSV M pro-
ein by SeV-MVSV, the infected LLC-MK2 cells were la-
eled with [35S]Cys and [35S]Met, and the proteins were
recipitated with anti-VSV M serum. Analysis of the pro-
eins by SDS–PAGE showed that a specific protein band
f 28 kDa was precipitated from the SeV-MVSV-infected
ell lysates (Fig. 2A). The protein had the same mobility
s the VSV M protein expressed from pCD8-VSV-M, pos-
essing the VSV M cDNA under the T7 promoter, by
sing the vaccinia virus-mediated T7 transient expres-
ion system. This confirmed an expression of the VSV M
rotein in the SeV-MVSV-infected cells. Immunoprecipita-
ion from an equivalent amount of radiolabeled cell ly-
ates with anti-SeV serum demonstrated that the SeV
roteins synthesized in SeV-MVSV-infected cells were
ewer than those synthesized in SeV wt-infected cells
Fig. 2A).
We next investigated the morphology of the infected
ells. Virus-infected cells were stained with anti-SeV
abbit serum and FITC-conjugated anti-rabbit IgG anti-
ody after 24 h of infection (Fig. 2B). SeV-MVSV infection,
n contrast with SeV wt, produced apparent cell rounding
n accordance with the cell rounding effect of the VSV M
rotein (Blondel et al., 1990; Lyles and McKenzie, 1997),
ndirectly confirming VSV M synthesis in the SeV-MVSV-
nfected cells. Because immunofluorescent staining with
nti-VSV M antibody failed to detect strong signals in the
eV-MVSV-infected cells (data not shown), this raised the
ossibility that the VSV M protein had been released
rom the cells as described previously (Li et al., 1993;
ustice et al., 1995) and that only small portions remained
n the cells.
rotein release from the SeV-MVSV-infected cells to
he culture medium
To assess the possibility that the VSV M protein was
eleased to the culture medium, the VSV M protein was
uantified by Western blotting. Proteins in the medium or
he cell lysates were concentrated, analyzed by SDS–
AGE, and transferred onto a PVDF membrane. Probing ihe membrane with anti-VSV M serum demonstrated that
75% of the VSV M protein was in the medium and
25% remained in the cells (Fig. 2C). A similar result also
as obtained in the BHK-21 cells infected with SeV-MVSV
data not shown). This shows an efficient release of VSV
from cells to the medium. Another possibility that
ntracellular VSV M is degraded should be noted, how-
ver, because some VSV M proteins were partially de-
raded in the cells (Fig. 2C). When the medium at 24 h
.i. was centrifuged at 100,000g for 60 min, the VSV M
rotein was detected in the pellet, not in the supernatant
data not shown), indicating that the VSV M protein had
een released as a precipitable form by ultracentrifuga-
ion.
Another set of membranes from the same experiment
as probed with anti-SeV serum to analyze the SeV
roteins. The SeV M protein was predominant in the
edium, whereas all the SeV proteins were detected in
he cell (Fig. 2C). To detect the other SeV proteins in the
edium, the experimental scale was expanded; the me-
ium from four 10 cm-dishes of the SeV-MVSV-infected
ells was concentrated and analyzed in a similar way.
he results showed that the other SeV proteins were in
he medium though in lower amounts compared with the
protein. This unproportional release of SeV proteins
as particular in this system because all of the SeV
roteins were proportionally released from the SeV wt-
nfected LLC-MK2 cells to the culture medium (data not
hown).
Furthermore two species of the SeV M protein could
e detected in the medium. It has been shown that the
lower migrating band, designated as the B band, rep-
esents the M protein phosphorylated at the 70th residue
rom the N terminus, whereas the faster migrating band
epresents the unphosphorylated M (Lamb and Choppin,
977; Sakaguchi et al., 1997). [32P]phosphate labeling of
he SeV-MVSV-infected cells demonstrated that phosphor-
lated M protein was actually released to the medium
data not shown). These results, therefore, indicate that
he SeV M protein, including its phosphorylated species,
as efficiently released to the medium.
high level of hemagglutinating activity in the
eV-MVSV-infected medium
The virus infectivity and HA of the culture supernatant
ere investigated. Confluent monolayers of LLC-MK2
ells were infected with SeV-MVSV, SeV/SpLuc, or SeV wt
t an input m.o.i. of 5. The medium was totally replaced
ith fresh medium every 12 h, and the accumulated virus
n the medium during the period was obtained. An infec-
ivity assay showed that infectious virus was released
rom the SeV-MVSV- and SeV/SpLuc-infected cells less
fficiently than from the SeV wt-infected cells (Fig. 3).
his is almost consistent with the results of virus growthn eggs.
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233DOUBLE-LAYERED MEMBRANE VESICLES BY VSV MHA titers, however, showed a distinct pattern. The HA
f SeV-MVSV was as high as that of SeV wt during the
ourse of infection and much higher than that of SeV/
pLuc (Fig. 3). HA was higher than expected from the
nfectivity in the SeV-MVSV infection; there was a dissoci-
tion between infectivity and HA. This raised the possi-
ility that the SeV HN protein was released to the culture
edium in a form distinct from virus particles, possibly
ssociating with VSV M.
lectron microscopic observation of the
eV-MVSV-infected LLC-MK2 cells
To further characterize the release of the VSV M pro-
ein, the LLC-MK2 cells were infected with SeV-M
VSV at an
.o.i. of 5, fixed after 20 h, and observed by electron
icroscopy. Large vesicles, which were probably in the
udding process, were observed on the cell surface (Fig.
A and 4B). The vesicles had a diameter of 800 6 500 nm
mean 6 standard deviation) by measuring 30 vesicles.
he actual diameter could be the same or more than the
alue. Our study further demonstrated the detailed struc-
ure of the vesicle: the plasma membrane and an intra-
ellular vesicle membrane appeared to be gluded at the
udding site (Figs. 4C, 4D, and 4F; the adhering site is
hown by an arrow). Accordingly, the vesicles had two
dhering lipid bilayers: the outer membrane was derived
rom the plasma membrane and the inner one possibly
rom an intracellular vesicle.
It was observed that the cytosol was sandwiched
etween the outer and inner membranes (Figs. 4F and
G). This may mark an intermediate stage during the
ormation of the vesicle, or the cytosol may be incorpo-
ated into the double-membrane vesicle in the end. It
FIG. 2. (A) Synthesis of the VSV M protein in the SeV-MVSV-infected
cells. LLC-MK2 cells were infected with SeV-M
VSV or wild-type SeV at an
m.o.i. of 10 or mock infected and labeled with [35S]Cys and [35S]Met for
30 min at 7 h p.i. Proteins were precipitated with anti-VSV M antiserum
or anti-SeV antiserum and analyzed by 15% SDS–PAGE. A specific
protein band (;28 kDa) was found in SeV-MVSV infection when precip-
itated with anti-VSV M antiserum. For reference, the VSV M protein was
expressed from cDNA by the transient expression system with the
vaccinia virus possessing the T7 RNA polymerase gene. (B) Morphol-
ogy of the SeV-MVSV-infected cells. LLC-MK2 cells on a coverslip were
infected with SeV-MVSV (a) or SeV wt (b) at an m.o.i. of 5 and incubated
for 24 h. The cells were fixed, permealized, and treated with anti-SeV
antiserum and FITC-labeled anti-rabbit antibody followed by immuno-
fluorescent microscopy. (C) Release of the VSV M protein and the SeV
proteins from the infected cells. LLC-MK2 cells in 6-cm dishes were
infected with SeV-MVSV at an m.o.i. of 5, and after 1 or 24 h, the medium
and cells were harvested separately. Proteins were concentrated by
precipitation with trichloroacetic acid, and an equivalent amount of the
proteins was loaded onto 15% SDS–PAGE and transferred to a PVDF
membrane. The membrane was incubated with anti-VSV M antiserum
or anti-SeV antiserum together with peroxidase-conjugated anti-rabbit
IgG antibody, followed by staining with DAB and hydrogen peroxide.
(Large scale): the medium from four 10-cm dishes was analyzed in a
similar manner.
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234 SAKAGUCHI ET AL.lso was found that a large vesicle formed a complex
hape (Fig. 4H) and that small particles were attached to
he vesicle membranes (Figs. 4C, 4F, and 4G). The ves-
cles seemed to have heterogeneity.
Immunogold-labeling demonstrated that anti-VSV M
ntisera exclusively reacted with the double-membrane
egion of the vesicles probably at various steps during
udding (Figs. 5A–5C). The antibody did not react with
he plasma membrane alone or an intracellular vesicle
embrane alone (Fig. 5). It appears that VSV M protein
rings together the two layers of the membranes, form-
ng the double-membraned vesicle.
ractionation of the membranes released from the
eV-MVSV-infected LLC-MK2 cells
We further analyzed the membranes released from the
eV-MVSV-infected cells. The culture medium from the
eV-MVSV-infected cells metabolically labeled with
35S]Cys and [35S]Met was concentrated by ultracentrifu-
ation and then fractionated by sucrose density equib-
ium ultracentrifugation. Each fraction was processed for
mmunoprecipitation with a mixture of anti-SeV and anti-
SV M sera and analyzed by SDS–PAGE. The fractions
ere broadly divided into three portions by distribution of
FIG. 3. Dissociation of infectivity and HA of SeV-MVSV. Confluent LLC
t at an m.o.i. of 5 CIU/cell and maintained in 1 ml of MEM. At the time
A in the medium were measured. The means of the two independeniral proteins (Fig. 6). The fraction of ,1.06 g/ml (Fig. 6, fraction 2; top fraction) contained a large amount of VSV
proteins and the SeV F and HN glycoproteins but not
eV M, N, and P proteins. The fractions of 1.11–1.15 g/ml
Fig. 6, fractions 8–10; middle fractions) contained SeV M
rotein as well as VSV M and SeV glycoproteins but not
eV N and P proteins. The fractions of 1.17–1.19 g/ml (Fig.
, fractions 14–16; heavy fractions), which had the same
ensity as SeV wt, contained all of the SeV proteins with
trace amount of VSV M protein.
Each of the top, middle, and heavy fractions was
ooled and concentrated by ultracentrifugation and ob-
erved by electron microscopy. Negative staining
howed that the top fraction mainly contained large ves-
cles (.600 nm in diameter; Figs. 7A and 7B), and thin
ectioning demonstrated that the fractions contained
ighly complex membranous structures (Figs. 7C–7E).
hese were probably produced when a simple mem-
rane vesicle collapsed and folded during the treatment
f samples. Alternatively, this phenomenon may reflect a
omplex budding form observed in the thin sectioning of
he infected cells (Fig. 4H). On the other hand, the heavy
ractions contained uniform small particles (,200 nm in
iameter; Figs. 8F–8H). Viral spikes and nucleocapsids
ere observed in the heavy fractions. Considering these
ells in a 3.5-cm dish were infected with SeV-MVSV, SeV/SpLuc, or SeV
ted, the medium was replaced with fresh medium, and infectivity and
iments were plotted.-MK2 c
indicaindings together with the density and protein profiles
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235DOUBLE-LAYERED MEMBRANE VESICLES BY VSV Mescribed above, we concluded that the top fraction
ontained the vesicles and the heavy fractions contained
eV particles, indicating that vesicles and SeV particles
re independently released from the cells. One thing to
e noted is that the SeV protein ratio in the heavy frac-
FIG. 4. Vesicles released from the SeV-MVSV-infected cells have two
f 5, and after 20 h the cells were fixed with 1% isotonic glutaraldehyd
mbedded in epoxy resin, and sectioned for electron microscopy. The bu
f the two membranes (C, D, and F). It was observed that the cytosol
as found that a large vesicle formed a complex shape (H), and that s
mm in (A) and 500 nm in (B–H).ions is different from that in normal SeV virions. The wractions had less N and P proteins (Fig. 6), suggesting
hat the trace amount of VSV M interferes with the SeV
NP incorporation to the fractions.
Immunogold labeling in negative staining showed that
nti-SeV F or anti-SeV HN monoclonal antibody reacted
of membrane. SeV-MVSV was inoculated to LLC-MK2 cells at an m.o.i.
postfixed with 1% osmium tetroxide. Samples then were dehydrated,
vesicles had double membranes, and arrows denote the adhering sites
ndwiched between the outer and inner membranes (F and G); it also
rticles attached to the vesicle membranes (C, F, and G). Bars indicatelayers
e and
dding
was sa
mall paith the vesicle in the top fraction (Figs. 7A and 7B),
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236 SAKAGUCHI ET AL.uggesting that the vesicle has SeV glycoproteins on its
urface. This is consistent with the protein profile of the
op fraction (Fig. 6) and a dissociation between infectivity
nd HA (Fig. 3). The gold particles with a size of 5 nm
ere clustered, not homogeneous, and the density of the
old particles was not so high as that seen in SeV
articles in the heavy fractions (Fig. 8G), showing a
eterogeneous and inefficient incorporation of the SeV
lycoproteins into the vesicle. Anti-VSV M antibody rarely
eacted with the vesicles. This was probably because
he VSV-M protein was inside the vesicles or between
he two membranes, preventing VSV M from directly
nteracting with the antibody.
The middle fractions with a density of 1.11–1.15 g/ml
ontained vesicles more heterogenous in size (200–1000
m in diameter) (Figs. 8A and 8B). Some vesicles reacted
ith anti-SeV F or anti-SeV HN but some did not, show-
ng a more heterogenous distribution of SeV glycopro-
eins (Figs. 8A and 8B). Thin sectioning demonstrated not
nly membranous structures but also membranes asso-
iated with electron dense materials, probably derived
rom the cytosol (Figs. 8C–8E). This is probably why the
iddle fractions have a higher density than the top frac-
ion.
The middle fractions were characterized by the pres-
nce of a large amount of SeV M protein (Fig. 6). SDS–
AGE in a 10% gel showed that the SeV M protein in the
iddle fractions migrated more slowly than that in the
eavy fraction (Fig. 6, lower panel, band B). This shows
hat phosphorylated SeV M protein, which was shown to
e released to the medium by Western blotting in Fig. 2C,
FIG. 5. The VSV M protein resides in the double-membrane region. S
ixed with periodate-lysine-paraformaldehyde fixative after 20 h. The c
owicryl K4M. Ultrathin sections were reacted with anti-VSV M antibo
ntiserum exclusively reacted with the double membrane region. (A), (
E, vesicle; CY, cytosol. Bar 5 200 nm.s located in the middle fractions. In a usual SeV infec- wion, only unphosphorylated M protein is incorporated
nto a virus particle and released to the medium,
hereas phosphorylated M remains in the cells (Lamb
nd Choppin, 1977). This is consistent with the fact that
he virions in the heavy fractions mainly have unphos-
horylated M protein (Fig. 6, lower panel). Release of the
hosphorylated M protein thus is considered to be inde-
endent of usual SeV maturation. It should be noted that
n additional feature of the middle fractions was the
bsence of SeV N and P proteins in spite of the presence
f SeV M proteins. This suggests that the phosphory-
ated M protein could not bind to the nucleocapsids.
utonomous release of VSV M from the expressed
ells without using a virus vector
There is a possibility that VSV M is released to the
edium with the aid of SeV vector proteins, especially F
nd HN proteins. To investigate this possibility, we ex-
ressed VSV M from plasmid without using a virus vec-
or. The VSV M protein was synthesized in the trans-
ected cells but with lower amounts compared with each
f the SeV proteins probably due to its cytotoxic effect.
he medium contained a significant amount of VSV M
Fig. 9); ;25% of the synthesized protein was released to
he medium. This is compatible with or more than the
SV M released from the SeV-MVSV-infected cells. For the
eV proteins expressed by the same system, significant
mounts of F and M proteins were also found in the
edium. Considering protein synthesis in the cells, how-
ver, only 3.3% of the F protein and 1.8% of the M protein
V was inoculated to LLC-MK2 cells at an m.o.i. of 5, and the cells were
en were dehydrated in a graded series of ethanol and embedded in
10 nm colloidal gold-conjugated anti-rabbit IgG antibody. Anti-VSV M
(C) may represent various steps of the VSV M budding. ME, medium;eV-MVS
ells th
dy and
B), andere released into the medium, whereas negligible
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237DOUBLE-LAYERED MEMBRANE VESICLES BY VSV Mmounts of the HN, P, or N protein were found in the
edium of the expressing cells (Fig. 9). These results
how an intrinsic ability of VSV M to go out of the cells.
n contrast, the SeV proteins were basically shown to
ack a releasing activity, although SeV M and F proteins
ight have a weak activity. SeV proteins therefore were
onsidered to be released into the culture medium, be-
FIG. 6. The released vesicles were broadly divided into three parts
y sucrose density gradient ultracentrifugation. Confluent monolayers
f LLC-MK2 cells were infected with SeV-M
VSV at an input m.o.i. of 5. At
h p.i., the medium was replaced with 5 ml of DMEM containing
35S]Pro-mix and one-fifth concentration of cold cysteine and methio-
ine. At 24 h p.i., infection, the medium was harvested, clarified by a
ow-speed centrifugation, and processed for ultracentrifugation at
00,000g for 60 min. The pellet then was suspended in PBS, and
ayered on the top of a 20–50% sucrose continuous density gradient,
nd the tube was centrifuged at 24,000 rpm for 18 h with a SW40 rotor.
roteins in each fraction of even numbers were precipitated with a
ixture of anti-SeV and anti-VSV M antisera and analyzed by 15%
DS–PAGE and autoradiography (top). Density of the gradient (g/ml)
nd the density of wild-type SeV virions are shown below the top panel.
he samples from fractions 8–16 were re-analyzed by a 10% gel (bot-
om). M, immunoprecipitation of the SeV-MVSV-infected cells as a
arker.ng implicated in the release of VSV M. fDISCUSSION
In the present study, we expressed the VSV M protein
y using a SeV vector. The expressed VSV M was effi-
iently released to the culture medium. We were able to
bserve details of the released vesicle by electron mi-
roscopy. The vesicles, probably in the budding process,
ere on the surface of the infected cells. The vesicles
ad two adhering membranes; one was derived from the
lasma membrane and the other possibly from an intra-
ellular vesicle. Immuno-colloidal gold labeling demon-
trated that the VSV M protein was exclusively located in
he double-membrane region. Thus VSV M appeared to
oin the two membranes, forming the double-lipid bilay-
rs. The VSV M protein on the inner face of the plasma
embrane is considered to bind to intracellular vesicle
embranes in the absence of the VSV RNP, and the
inding could be a driving force for efficient budding. The
elease of VSV M after evagination of the plasma mem-
rane has been observed when expressed in insect cells
n the absence of other VSV proteins or when a temper-
ture-sensitive mutant of the M protein, tsO23, is propa-
ated at a nonpermissive temperature (Li et al., 1993;
yles et al., 1996). The vesicles were observed to have
hicker membranes than usual and to be “empty,” lacking
ytoplasmic components such as ribosomes or cytoskel-
tal elements (Li et al., 1993; Lyles et al., 1996). The
resent work also explains the membrane thickness and
ow the cytoplasmic components were excluded from
he vesicle.
The origin of the internal layer of the vesicle is un-
nown. Not so many intracellular large vesicles were
ound in the cytosol either of the SeV-MVSV-infected cells
Fig. 4A) or uninfected LLC-MK2 cells (data not shown).
he intracellular vesicles seemed to appear under the
lasma membrane in the SeV-MVSV-infected cells. One
ossibility is that the inner layer is derived from the
ransport vesicles in exocytosis or membrane recycling
f endocytosis. In that case, the VSV M protein, which
inds to the cytoplasmic surface of the plasma mem-
rane, inhibits fusion of the docked transport vesicles to
he plasma membrane. The disturbed transport vesicles
ight subsequently fuse to each other, forming a large
esicle. This issue should be clarified by the further
tudy.
The present study confirmed and extended previous
esults about the assembly of VSV and SeV. First, the
nteraction between the VSV M protein and the SeV
lycoproteins were suggested. Sucrose density equilib-
ium gradient ultracentrifugation separated the released
embranes into three parts; the top, middle, and heavy
ractions. The top fraction with a low density (1.06 g/ml or
ess) mainly had large vesicles containing VSV M, SeV F,
nd HN proteins. SeV glycoproteins were revealed to be
ncorporated into the vesicles by electron microscopy. A
oreign glycoprotein has been shown to be efficiently
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238 SAKAGUCHI ET AL.ncorporated into the VSV particle, though less efficiently
ompared with the native G protein (Schnell et al., 1996;
retzschmar et al., 1997). SeV glycoproteins may be in-
orporated into the vesicles in a similar manner.
Second, the interaction between the VSV M and SeV M
roteins also were suggested, because the middle frac-
ions (1.11–1.15 g/ml) contained a significant amount of
he SeV M protein as well as VSV M and SeV F and HN
roteins. The interaction between the VSV M and SeV M
roteins might be indirect, however, because no evi-
ence was obtained by coprecipitation assay that the
wo M proteins interact with each other (data not shown).
he VSV M protein was efficiently released to the culture
edium when expressed without using a viral vector.
his denies involvement of the proteins from the viral
ectors in the release of VSV M and shows that the VSV
protein has a releasing activity in itself. The SeV
roteins in the top and middle fractions are considered
o be passively implicated in the release of VSV M.
Third, besides these positive interactions between the
FIG. 7. The top fractions have large membranous structures. The top fr
ith PBS, and recentrifuged at 100,000 g for 60 min. The pellet was tre
olloidal gold-conjugated anti-mouse IgG antibody, and simultaneous
nti-rabbit IgG antibody (A and B), followed by negative staining. Altern
ixed with glutaraldehyde and osmium tetroxide after 24 h. The agarose
icroscopy (C–E). Bar 5 200 nm.SV M and SeV membrane proteins, negative interac- eions of VSV M and the phosphorylated SeV M protein
ith SeV RNP were suggested. Lack of SeV RNP in the
op and middle fractions clearly shows the lack of inter-
ction between VSV M and SeV RNP. No SeV RNP was
etected in the middle fractions, and the SeV M proteins
n the fractions were mainly phosphorylated. We thus
uggested that the phosphorylated SeV M cannot bind to
he nucleocapsids. This is consistent with the fact that
nly unphosphorylated M protein is incorporated into a
irus particle in a usual SeV infection (Fig. 6; Lamb and
hoppin, 1977). On the other hand, the cytosolic compo-
ents in the middle fractions may be released by asso-
iating with the phosphorylated SeV M because it was a
articular viral component observed in the middle frac-
ions but not in the other fractions. This is also consistent
ith an interaction of phosphorylated M with cytoskel-
tons as described previously (Sanderson et al., 1995).
In conclusion, the VSV M protein was shown to form
wo-membraned vesicles upon release from the cell. The
elease of VSV M vesicles was very efficient. Using a SeV
after sucrose density gradient ultracentrifugation were pooled, diluted
th anti-SeV F (A) or anti-HN mouse monoclonal antibody (B) and 5 nm
ted with anti-VSV M antiserum and 10 nm colloidal gold-conjugated
the pellet was embedded in 1% low-temperature melting agarose and
was dehydrated, embedded in epoxy resin, and sectioned for electronactions
ated wi
ly trea
atively,
blockxpression vector, possible positive or negative interac-
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239DOUBLE-LAYERED MEMBRANE VESICLES BY VSV Mions between VSV M and SeV proteins could be ob-
erved, and using a plasmid expression system, VSV M
as shown to have a releasing activity per se. Investi-
ating the activity of VSV M may lead to an insight into
ow the protein interacts with host membranes, inducing
FIG. 8. Electron microscopic observation of the middle and heavy
ltracentrifugation were pooled, diluted with PBS, and recentrifuged at 1
s described in the legend of Fig. 7. Negative staining of the middle fra
ntibodies (B), visualized with 5 nm colloidal gold, and anti-VSV M anti
he middle fractions (C–E). Negative staining of the heavy fractions tre
nti-VSV M antiserum, visualized with 10 nm colloidal gold (F and G).he formation of double membranes, in further study. 1MATERIALS AND METHODS
ells, viruses, and antibodies
LLC-MK2 and BHK-21 cells were grown in Eagle’s
inimal essential medium (MEM) supplemented with
ns. The middle and heavy fractions after sucrose density gradient
g for 60 min. Negative staining and ultrathin sectioning were performed
after treatment with a mixture of anti-SeV F (A) or anti-HN monoclonal
visualized with 10 nm colloidal gold (A and B). Ultrathin sectioning of
th anti-HN monoclonal antibodies, visualized with 5 nm colloidal, and
n sectioning of the heavy fractions (H). Bar 5 200 nm.fractio
00,000
ctions
serum,
ated wi0% fetal calf serum. SeV was propagated by inoculation
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240 SAKAGUCHI ET AL.o 10-day-old embryonated chicken eggs and further
ncubation at 33°C for 3 days. The infectivity of SeV was
easured with an immunofluorescent infectious focus
ssay (Kiyotani et al., 1990) and expressed as cell infec-
ious units (CIU)/ml. Hemagglutinating activity (HA) was
easured by the standard method using a microtiter
late. Recombinant vaccinia virus vTF7.3, carrying the
FIG. 9. The VSV M protein is efficiently released from cells when ex
, F, and HN proteins was subcloned, respectively, into the pCAGGS/M
t 6 h posttransfection, the medium was replaced with DMEM containi
osttransfection. The medium was mixed with 23 concentrated RIPA b
ipitation as described under Materials and Methods. Proteins were an
f released proteins to the medium. Each value is from two independeacteriophage T7 RNA polymerase gene (Fuerst et al., a986), was provided by Dr. Bernard Moss (National In-
titute of Health, Bethesda, MD). The vaccinia virus was
ropagated in CV1 cells, and infectivity was assayed by
he standard plaque method. Rabbit antiserum against
he VSV M protein was produced by immunizing rabbits
ith the histidine-tagged VSV M protein expressed in
scherichia coli. A mixture of monoclonal antibodies
d without using a viral vector. (A) The cDNA of the VSV M, SeV M, N,
smid, and LLC-MK2 cells were transfected with each of the plasmids.
MBq/ml of [35S]Pro-mix and 140 diluted cysteine and methionine. At 24 h
nd the cells were lysed with the RIPA buffer, followed by immunopre-
by 12% SDS–PAGE. SeV-MVSV, SeV-MVSV-infected cells. (B) Proportions
eriments.presse
CS pla
ng 3.7
uffer, a
alyzed
nt expgainst SeV F protein was prepared from F-49, F-128, and
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241DOUBLE-LAYERED MEMBRANE VESICLES BY VSV M-881 and that against SeV HN protein from HN-43,
N-312, and HN-892 (Tozawa et al., 1986).
lasmids
The cDNA of the M protein of VSV New Jersey serotype
as generated by polymerase chain reaction (PCR) follow-
ng reverse transcription of the genomic RNA, and sub-
loned to the pCDM8 vector (pCDM8-MVSV). The cDNA was
urther amplified by PCR using the primers,
9-ATCTTGCGGCCGCAGTAAGAAAAACTTAGGGTGAAAGT-
CACTTCACAATGAGTTCCTTCAAGAA-39 and 59-AGTTAG-
GGCCGCTACTATTACTTAAATGGACTCAA-39, and sub-
loned into the NotI site of pSeV18c(1). The plasmid has
he whole SeV genome DNA flanked by the T7 promoter
nd the hepatitis delta ribozyme, and the 18 base NotI linker
nserted at the 39 noncoding region of the N gene (Fig. 1A;
. Kato et al., submitted). The resultant plasmid,
SeV18c(1)-MVSV, has the VSV M cDNA between the N and
/C genes (Fig. 1B). The nucleotide sequence of the VSV M
ene including the insertion site was confirmed after sub-
loning. Another DNA construct, in which the SeV M gene
as totally replaced with the VSV M cDNA [pSeV(1)-MVSV],
as constructed as described previously (Sakaguchi et al.,
997). The VSV M cDNA also was subcloned into a mam-
alian expression vector, pCAGGS/MCS, which has the
ytomegalovirus immediate early enhancer and the
hicken b-actin promoter upstream of a multicloning site
Niwa et al., 1991).
ecovery of SeV from cDNA
SeV was recovered from pSeV18c(1)-MVSV as de-
cribed by Kato et al. (1996). Briefly, 1.2 3 107 of LLC-MK2
ells in a 6-cm dish were infected with vTF7.3 at an m.o.i.
f 2 PFU/cell, and transfected with pSeV18c(1)-MVSV (10
g) and the plasmids encoding trans-acting proteins,
GEM-N (5 mg), pGEM-P (2.5 mg), and pGEM-L (5 mg)
ith the aid of a liposomal transfection reagent, DOTAP
Boehringer-Mannheim, Mannheim, Germany). The cells
hen were maintained in MEM containing 40 mg/ml of
ytosine b-D-arabinofuranoside (Ara-C; Sigma, St. Louis,
O) and 100 mg/ml of rifampicin (Sigma). After 2 days,
he cells were suspended in 1 ml of Dulbecco’s phos-
hate-buffered saline (PBS) and disrupted with a brief
onication. The cell lysates were inoculated to 10-day-
ld embryonated chicken eggs.
rotein analysis by metabolic labeling and
mmunoprecipitation
Confluent monolayers of LLC-MK2 cells in a 3.5-cm
ish were infected with SeV at an m.o.i. of 20. For protein
xpression from cDNA, subconfluent monolayers of LLC-
K2 cells were infected with vaccinia virus vTF7.3 at an
.o.i. of 10 PFU/cell and transfected with plasmid DNA
y using DOTAP. After 6 h, the cells were labeled with
35S[Cys] and [35S]Met ([35S]Pro-mix; 3.7 MBq/ml; Amer- (ham, Arlington Heights, IL) for 30 min in methionine-
nd cysteine-free Dulbecco’s modified MEM (DMEM;
ife Technologies, Rockville, MD). The cells were lysed
n radioimmuno-precipitation assay (RIPA) buffer [10 mM
ris–HCl, pH 7.4, 1% Triton X-100, 1% sodium deoxy-
holate, 0.1% sodium dodecyl sulfate (SDS), 150 mM
aCl, 50 mM iodoacetamide, and 1 mM PMSF (phenyl-
ethanesulfonyl fluoride)]. Polypeptides were immuno-
recipitated with anti-SeV serum or anti-VSV M anti-
erum and analyzed by 15 or 10% SDS–polyacrylamide
el electrophoresis (PAGE) as described previously (Sa-
aguchi et al., 1996). Radioactivity was analyzed by using
Fujix BAS 2000 image analyzer (Fuji Photo Film, Tokyo,
apan).
For protein expression from plasmid without using a
irus vector, the pCAGGS/MCS plasmid was introduced
o subconfluent LLC-MK2 cells in a 6-cm dish with the
ipofectAMINE and PLUS reagents (Life Technologies)
ollowing the manufacturer’s instruction. After 6 h post-
ransfection, the cells were labeled for 20 h with 3.7
Bq/ml of [35S]Pro-mix in DMEM in which cysteine and
ethionine concentrations were reduced to 140. The me-
ium was mixed with an equal volume of 23 concen-
rated RIPA buffer, and the cells were lysed in RIPA buffer.
he proteins were further immunoprecipitated and ana-
yzed as described above.
mmunofluorescent staining of the infected cells
LLC-MK2 cells on a coverslip were infected with SeV at
n m.o.i. of 5, and incubated for 24 h in MEM. The cells
ere fixed with 1% formalin in PBS for 20 min at room
emperature, permealized with 0.1% Triton X-100 for 2
in, and sequentially incubated with anti-SeV serum and
luorescein isothiocyanate (FITC)-conjugated anti-rabbit
gG antibody (Organon Teknika, West Chester, PA). Then
he cells were observed with a VANOX-T fluorescent
icroscope (Olympus, Tokyo, Japan).
estern blotting
LLC-MK2 cells in 6-cm dishes were infected with
eV-MVSV at an m.o.i. of 5, and the medium and cells were
arvested separately after 1 or 24 h. The medium was
larified by a low-speed centrifugation, and the cells
ere solubilized with RIPA buffer and clarified by centrif-
gation at 15,000 rpm for 20 min in a microfuge. The
roteins in the fractions were concentrated by precipita-
ion with trichloroacetic acid. An equivalent amount of
he precipitated pellet was loaded onto 15% SDS–PAGE
nd transferred to a polyvinylidene difluoride (PVDF)
embrane (Millipore, Bedford, MA). The membrane was
robed with anti-VSV M antiserum and peroxidase-con-
ugated anti-rabbit IgG antibody (Organon Teknika), fol-
owed by visualization with 3,39-diaminobenzidine
Dojindo, Kumamoto, Japan) and hydrogen peroxide.
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242 SAKAGUCHI ET AL.ucrose density gradient equibrium
ltracentrifugation
Confluent monolayers of LLC-MK2 cells in four 10-cm
ishes were infected with SeV-MVSV at an input m.o.i. of 5.
t 4 h p.i., the medium was replaced with 5 ml of DMEM
hat had 740 kBq/ml of [35S]Pro-mix and one-fifth concen-
ration of cold cysteine and methionine. At 24 h p.i., the
edium was harvested, clarified by a low-speed centrif-
gation, and ultracentrifuged at 100,000g for 60 min. The
ellet then was suspended in a small volume of PBS,
ayered on the top of a 20–50% sucrose linear density
radient, and centrifuged at 24,000 rpm for 18 h in a
W40 rotor (Beckman, Palo Alto, CA). After the spin,
ractions were taken with an Auto Densi-Flow fractiona-
or (Labconco, Kansas City, MO). Each fraction (0.5 ml)
as mixed with an equal volume of 23 concentrated
IPA buffer, and the proteins were immunoprecipitated
ith a mixture of anti-SeV and anti-VSV M antisera, and
nalyzed by 15% SDS–PAGE and autoradiography.
lectron microscopy
Electron microscopy was performed as described pre-
iously (Uchiyama and Uchida, 1988) with some modifi-
ation. The infected cells were washed with PBS and
ixed with 1% isotonic glutaraldehyde for 1 h on ice. For
bservation of sucrose fractions, the fractions were pre-
ared from unlabeled SeV-MVSV-infected cells in 27 of
0-cm dishes as described above. A part of the fractions
as analyzed by SDS–PAGE followed by silver staining.
ractions of a similar protein profile were pooled, diluted
ith PBS, and recentrifuged at 100,000g for 60 min. The
ellet was resuspended in a small volume of PBS and
mbedded in a 1% low-melting-temperature agarose,
ollowed by fixation. The fixed cells or the agarose blocks
ere postfixed with 1% osmium tetroxide for 1 h on ice.
he specimens then were dehydrated in a graded series
f ethanol, immersed in propylene oxide, and embedded
n Epon 812 (TAAB, Aldermaston, England). Ultrathin sec-
ions were examined under a JEOL JEM-1200EX II trans-
ission electron microscope.
mmunoelectron microscopy
The sucrose fractionated samples prepared as de-
cribed above were placed on Formvar carbon-coated
ickel grids and reacted with a mixture of mouse mono-
lonal antibody to HN or F of SeV and rabbit antiserum to
SV M followed by a reaction with a mixture of colloidal
old (5 nm in mean diameter)-labeled antibody to mouse
gG and colloidal gold (10 nm in mean diameter)-conju-
ated antibody to rabbit IgG (Amersham). The grids then
ere stained with 4% uranyl acetate.
Immunoelectron microscopy of infected cells was per-
ormed basically as described previously (Uchiyama et
l., 1994). Briefly, the infected cells were washed withBS and fixed with periodate-lysine-paraformaldehyde
ixative on ice. The fixed cells were dehydrated in a
raded series of ethanol and embedded in Lowicryl K4M
Electron Microscopy Sciences, Ft. Washington, PA) at
30°C. Ultrathin sections on grids were reacted with
abbit antiserum against VSV M followed by a reaction
ith colloidal gold (10 nm in mean diameter)-conjugated
ntibody to rabbit IgG. The ultrathin sections then were
tained with uranyl acetate and observed under a trans-
ission electron microscope.
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